MedTrace Logo

Simvastatin Versus MTA in Pulpotomy of Immature Permanent Molars

NCT05878158 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2023-05-26

No results posted yet for this study

Summary

the study will be done to evaluate the clinical and digital radiographic success of simvastatin versus MTA in pulpotomy of immature permanent molars

Conditions

  • Pulp Exposure, Dental

Interventions

DRUG

Simvastatin

pulpotomy of immature permanent teeth

Sponsors & Collaborators

  • Ahmad Elheeny

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2024-01-01
Completion
2024-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05878158 on ClinicalTrials.gov